Back
Neurocrine Biosciences Vs. Belite Bio Industry Stock Comparison
Buy
57
NBIX
Neurocrine Biosciences
Last Price:
126.63
Seasonality Move:
17.1%
Buy
89
BLTE
Belite Bio
Last Price:
67.60
Seasonality Move:
11.16%
Buy
57
Neurocrine Biosciences (NBIX)
is a Buy
Is Neurocrine Biosciences a Buy, Sell or Hold?
- The current Neurocrine Biosciences [NBIX] share price is $126.59. The Score for NBIX is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- NBIX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
89
Belite Bio (BLTE)
is a Buy
Is Belite Bio a Buy, Sell or Hold?
- The current Belite Bio [BLTE] share price is $67.44. The Score for BLTE is 89, which is 78% above its historic median score of 50, and infers lower risk than normal.
- BLTE is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
NBIX Stock Price Chart
What is Neurocrine Biosciences's stock price today?
-
The Neurocrine Biosciences share price today is $126.59
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBIX is experiencing slight selling pressure.
BLTE Stock Price Chart
What is Belite Bio's stock price today?
-
The Belite Bio share price today is $67.44
The current trend is moderately bearish and BLTE is experiencing slight buying pressure.
NBIX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.71 | Buy |
| Relative Strength Index (14 RSI): | 58.7 | Buy |
| Chaikin Money Flow: | -135390 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (118.41 - 126.41) | Buy |
| Bollinger Bands (100): | (115.86 - 143.58) | Sell |
BLTE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.5 | Buy |
| Relative Strength Index (14 RSI): | 42.18 | Sell |
| Chaikin Money Flow: | 27107 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (67.71 - 82.51) | Sell |
| Bollinger Bands (100): | (44.39 - 68.09) | Buy |
NBIX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 124.04 | Buy |
| 20-day SMA: | 123.59 | Buy |
| 50-day SMA: | 118.99 | Buy |
| 200-day SMA: | 133.37 | Sell |
| 8-day EMA: | 125.23 | Buy |
| 20-day EMA: | 123.29 | Buy |
| 50-day EMA: | 123 | Buy |
| 200-day EMA: | 127.88 | Sell |
BLTE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 77.14 | Sell |
| 20-day SMA: | 77.31 | Sell |
| 50-day SMA: | 63.62 | Buy |
| 200-day SMA: | 50.02 | Buy |
| 8-day EMA: | 74.43 | Sell |
| 20-day EMA: | 74.55 | Sell |
| 50-day EMA: | 66.97 | Buy |
| 200-day EMA: | 52.46 | Buy |
Neurocrine Biosciences Earnings Growth & NBIX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.30 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.44 per share, and an increase next year of $1.13 per share.
Belite Bio Earnings Growth & BLTE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and an increase next year of $0.18 per share.
Neurocrine Biosciences Technical Analysis
| Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Belite Bio Technical Analysis
| Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||